RESUMEN
Depression is a worldwide problem with a great social and economic burden in many countries. In our previous research, we found that the expression of proBDNF/p75NTR/sortilin is upregulated in patients with major depressive disorder. In addition, the treatment of proBDNF antibodies reversed both the depressive behaviors and the reduced BDNF mRNA detected in our rodent chronic stress models. Antidepressant drugs are usually only effective in a subpopulation of patients with major depression with a delayed time window of 2-4 weeks to exert their efficacy. The mechanism underlying such delayed response is not known. In this study, we hypothesize that antidepressant drugs exert their therapeutic effect by modulating proBDNF/p75NTR and mature BDNF/TrkB signaling pathways. To test the hypothesis, C57 mice were randomly divided into normal control, chronic unpredictable mild stress (CUMS), vehicle (VEH), fluoxetine (FLU), and clozapine (CLO) groups. Behavioral tests (sucrose preference, open field, and tail suspension tests) were performed before and after 4 weeks of CUMS. The gene and protein expression of proBDNF, the neurotrophin receptor (p75NTR), sortilin, and TrkB in the cortex and hippocampus were examined. At the protein level, CUMS induced a significant increase in proBDNF, p75NTR, and sortilin production while the TrkB protein level was found to be lower in the cortex and hippocampus compared with the control group. Consistently, at the mRNA level, p75NTR expression increased with reduced BDNF/TrkB mRNA in both cortex and hippocampus, while sortilin increased only in the hippocampus after CUMS. FLU and CLO treatments of CUMS mice reversed all protein and mRNA expression of the biomarkers in both cortex and hippocampus, except for sortilin mRNA in the cortex and proBDNF in the hippocampus, respectively. This study further confirms that the imbalance between proBDNF/p75NTR/sortilin and mBDNF/TrkB production is important in the pathogenesis of depression. It is likely that antidepressant FLU and antipsychotic CLO exert their antidepressant-like effect correcting the imbalance between proBDNF/p75NTR/sortilin and mBDNF/TrkB.
Asunto(s)
Proteínas Adaptadoras del Transporte Vesicular/biosíntesis , Antidepresivos/farmacología , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Corteza Cerebral/metabolismo , Hipocampo/metabolismo , Glicoproteínas de Membrana/biosíntesis , Precursores de Proteínas/biosíntesis , Proteínas Tirosina Quinasas/biosíntesis , Receptores de Factor de Crecimiento Nervioso/biosíntesis , Estrés Psicológico/prevención & control , Animales , Conducta Animal/efectos de los fármacos , Clozapina/farmacología , Fluoxetina/farmacología , Masculino , Ratones , Transducción de Señal/efectos de los fármacosRESUMEN
A critical function of cells is the maintenance of their genomic integrity. A family of phosphoinositide-3-kinase-related protein kinases, which includes ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3 related (ATR) kinases, play key roles in sensing DNA damage. ATM and ATR were demonstrated in the cleavage stages of mouse embryo development. Genotoxic stress was imposed by exposure to ultraviolet (UV) radiation (causes DNA strand breaks) or cisplatin (causes strand cross-links). UV irradiation or cisplatin treatment of 2-cell embryos in the G(2) phase of the cell cycle caused DNA damage as defined by increased phosphorylation of the H2A histone family, member X (H2AFX; previously H2AX) variant. UV irradiation caused a stable G(2)-M arrest, and cisplatin treatment allowed progression through mitosis followed by activation of a G(1)-S checkpoint. Both checkpoints were transformation-related protein 53-independent. Caffeine (inhibits both ATM and ATR), but not KU55933 (ATM-selective inhibitor), reversed the G(2)-M block induced by UV, inferring a primary role for ATR in sensing this form of DNA damage. Caffeine and KU55933 were equally effective in reversing the cisplatin-induced G(1)-S block, implicating ATM as the primary sensing enzyme. Breaching of either checkpoint by treatment with caffeine or KU55933 allowed embryos to progress through several further cell cycles, yet none developed to blastocysts. The results show, to our knowledge for the first time, that the G(2)-M and G(1)-S cell-cycle checkpoints in the early embryo are differentially regulated by ATM and ATR in response to genotoxic stress and that they act as an initial point for containment of genomic damage. Under conditions of extensive or persistent DNA damage, the demise of the embryo is the ultimate method of protecting genomic integrity.
Asunto(s)
Proteínas de Ciclo Celular/metabolismo , Daño del ADN , Proteínas de Unión al ADN/metabolismo , Embrión de Mamíferos/enzimología , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Animales , Antineoplásicos , Proteínas de la Ataxia Telangiectasia Mutada , Ciclo Celular , Cisplatino , Embrión de Mamíferos/efectos de la radiación , Desarrollo Embrionario , Femenino , Ratones , Ratones Endogámicos C57BL , Embarazo , Rayos UltravioletaRESUMEN
OBJECTIVE: To evaluate the visual function of the visual display terminal (VDT) operators under the Multi-user system. METHOD: Subjective symptoms of the VDT operators under the Multi-user system were measured before and after work in the field study. Visual indices were measured at 8:15, 9:15, 10:15, 11:15, or 12:15 a.m. RESULT: No discomfort symptom was observed during the working time, and Longitudino-Kinetic visual acuity, and Critical flicker frequency didn't decrease. Refraction showed no significant decrease as compared with that at 8:15 except that of right eye measured at 12:15. CONCLUSION: The Visual function of the VDT operators remained good in the Multi-user's system.